These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 35305083)
21. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. Feldman ME; Apsel B; Uotila A; Loewith R; Knight ZA; Ruggero D; Shokat KM PLoS Biol; 2009 Feb; 7(2):e38. PubMed ID: 19209957 [TBL] [Abstract][Full Text] [Related]
22. Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis. Guo Y; Kwiatkowski DJ Mol Cancer Res; 2013 May; 11(5):467-73. PubMed ID: 23386687 [TBL] [Abstract][Full Text] [Related]
23. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction. Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721 [TBL] [Abstract][Full Text] [Related]
24. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421 [TBL] [Abstract][Full Text] [Related]
25. mTORC2 is required for proliferation and survival of TSC2-null cells. Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669 [TBL] [Abstract][Full Text] [Related]
27. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα). Dan HC; Ebbs A; Pasparakis M; Van Dyke T; Basseres DS; Baldwin AS J Biol Chem; 2014 Sep; 289(36):25227-40. PubMed ID: 24990947 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer. Mrozek EM; Bajaj V; Guo Y; Malinowska IA; Zhang J; Kwiatkowski DJ PLoS One; 2021; 16(4):e0248380. PubMed ID: 33891611 [TBL] [Abstract][Full Text] [Related]
29. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225 [TBL] [Abstract][Full Text] [Related]
30. Mammalian target of rapamycin and tuberous sclerosis complex. Wataya-Kaneda M J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878 [TBL] [Abstract][Full Text] [Related]
31. Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes. Hong-Brown LQ; Brown CR; Navaratnarajah M; Lang CH Alcohol Clin Exp Res; 2013 Nov; 37(11):1849-61. PubMed ID: 23895284 [TBL] [Abstract][Full Text] [Related]
32. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Huang J; Dibble CC; Matsuzaki M; Manning BD Mol Cell Biol; 2008 Jun; 28(12):4104-15. PubMed ID: 18411301 [TBL] [Abstract][Full Text] [Related]
33. Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway. Lin Y; Henderson P; Pettersson S; Satsangi J; Hupp T; Stevens C FEBS J; 2011 Jan; 278(2):354-70. PubMed ID: 21134130 [TBL] [Abstract][Full Text] [Related]
34. The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis. Kang YJ; Lu MK; Guan KL Cell Death Differ; 2011 Jan; 18(1):133-44. PubMed ID: 20616807 [TBL] [Abstract][Full Text] [Related]
35. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. Wang L; Harris TE; Lawrence JC J Biol Chem; 2008 Jun; 283(23):15619-27. PubMed ID: 18372248 [TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity. Zhan J; Chitta RK; Harwood FC; Grosveld GC Mol Cell Biochem; 2019 Jun; 456(1-2):123-134. PubMed ID: 30684133 [TBL] [Abstract][Full Text] [Related]
38. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Al-Regaiey KA; Masternak MM; Bonkowski M; Sun L; Bartke A Endocrinology; 2005 Feb; 146(2):851-60. PubMed ID: 15498882 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2 Jones AT; Narov K; Yang J; Sampson JR; Shen MH Neoplasia; 2019 Feb; 21(2):230-238. PubMed ID: 30622053 [TBL] [Abstract][Full Text] [Related]
40. ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling. Winter JN; Jefferson LS; Kimball SR Am J Physiol Cell Physiol; 2011 May; 300(5):C1172-80. PubMed ID: 21289294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]